BOSTON, Feb. 27, 2025 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics ...
WASHINGTON, March 14, 2025 (GLOBE NEWSWIRE) -- FTI Consulting, Inc. (NYSE: FCN) today announced that Dr. Ali Hortaçsu, the William M. Ogden Distinguished Service Professor of Economics at the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback